Skip to main content
Niagen Bioscience, Inc. logo

Niagen Bioscience, Inc. — Investor Relations & Filings

Ticker · NAGE ISIN · US1710774076 LEI · 529900OPI7B8JPXCVS70 US Manufacturing
Open in API
Filings indexed 954 across all filing types
Latest filing 2008-10-29 Director's Dealing
Country US United States of America
Listing US NAGE

About Niagen Bioscience, Inc.

https://www.niagenbioscience.com/

Niagen Bioscience, Inc. (formerly ChromaDex) is a bioscience company focused on the science of nicotinamide adenine dinucleotide (NAD+). The company aims to improve healthspan and support healthy aging by developing products that restore and optimize cellular NAD+ levels. Its core proprietary ingredient is Niagen®, a patented and clinically studied form of nicotinamide riboside (NR), a precursor to NAD+. Niagen® is the key component in the company's consumer dietary supplement brand, Tru Niagen®, and is also developed for the food, beverage, and pharmaceutical markets. The company's research is supported by numerous human clinical studies, a portfolio of over 50 owned and licensed patents, and collaborations with global research institutions.

Recent filings

Filing Released Lang Actions
MAIN DOCUMENT DESCRIPTION
Director's Dealing
2008-10-29 English
FORM S-8
Capital/Financing Update Classification · 95% confidence The document is a Form S-8 Registration Statement filed with the SEC by ChromaDex Corporation. Form S-8 is used to register securities to be offered under employee benefit plans, such as stock option plans. The document includes detailed information about the securities to be registered, the plan under which they are offered, and references to other filings like annual and quarterly reports. It is not a financial report, earnings release, or management discussion, but a registration statement related to capital raising through employee stock options. Therefore, it fits best under the category of Capital/Financing Update (CAP), which covers updates on company fundraising and capital structure changes. The document length (15,000 characters) and content confirm it is the registration statement itself, not just an announcement or certification.
2008-10-17 English
FORM S-8
Capital/Financing Update Classification · 95% confidence The document is a Form S-8 Registration Statement filed with the SEC. Form S-8 is used to register securities to be offered under employee benefit plans, such as equity incentive plans. The text includes detailed information about the registration of shares under the Second Amended and Restated 2007 Equity Incentive Plan, calculation of registration fees, incorporation by reference of other SEC filings, and legal undertakings. It is not an annual report, earnings release, or any other financial report but a capital market filing related to securities registration. According to the filing definitions, updates on company fundraising, financing activities, or capital structure changes fall under Capital/Financing Update (CAP). Since this document registers shares for issuance under an equity incentive plan, it is best classified as a Capital/Financing Update (CAP). The document length is substantial and contains detailed registration information, not just an announcement or notice, so it is not RPA or RNS. Therefore, the classification is CAP with high confidence.
2008-10-17 English
Regulatory Filings 2008
Regulatory Filings
2008-09-22 English
FORM 10-Q
Interim / Quarterly Report Q2 2008
2008-08-12 English
AUTO-GENERATED PAPER DOCUMENT
Regulatory Filings
2008-08-07 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.